Cumulus Oncology
4 known investors
Cumulus Oncology builds a risk-adjusted portfolio of preclinical-stage oncology drug assets, using a platform-agnostic, data- and milestone-driven curation process to advance cancer therapeutics for defined patient populations with high unmet medical need. The company aims to improve drug development success rates and create value through partnering, licensing, and exit opportunities for investors.
BiotechHealthtech
Founders & leadership
CW
Clare WareingCEO